With an ambition to push the boundaries of science and advance understanding of the underlying biology of disease, AstraZeneca has built one of the strongest small molecule and biologics pipelines in the biopharmaceutical industry. At the heart of our work is a deep commitment to addressing unmet medical need and delivering life-changing medicines to patients.

AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development and commercialization of primary and specialty care medicines that transform lives. Poised to launch more than 20 new medicines and indications within the next few years, AstraZeneca is focused on driving innovative science in three important areas of healthcare: Cardiovascular, Renal and Metabolic disease; Oncology; and Respiratory, Inflammation and Autoimmunity. Precision medicine and genomics is fundamental to the way AstraZeneca scientists work across all three areas, and in collaboration with world-leading academic partners in Canada and globally.

Globally, the company operates in more than 100 countries and its innovative medicines are used by millions of patients worldwide. In Canada, we employ more than 850 employees across the country and our AstraZeneca Canada headquarters are located in Mississauga, Ontario.

In addition to a rapidly expanding clinical footprint in Canada, AstraZeneca is engaged in a number of novel research partnerships with world-class researchers across the country. Tapping into the strong Canadian health sciences infrastructure, AstraZeneca Canada invested more than $102 million in Canadian R&D in 2018 alone.  AstraZeneca Canada was also recently designated a key Global Clinical Trial Delivery site for AstraZeneca globally – leading the development for more than 60 global clinical trials and playing an integral role in the development of many of AstraZeneca’s pipeline compounds in oncology, immuno-oncology and respiratory disease.

For more information about AstraZeneca Canada, please visit the company’s website at www.astrazeneca.ca.

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of primary and specialty care medicines that transform lives. Our primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease; Oncology; and Respiratory, Inflammation and Autoimmunity. For more information: www.astrazeneca.ca.